Free Trial

Glucose Health Q2 2023 Earnings Report

Glucose Health logo
$0.14 0.00 (-2.91%)
As of 12:54 PM Eastern

Glucose Health EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Glucose Health Revenue Results

Actual Revenue
$0.16 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Glucose Health Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Glucose Health Earnings Headlines

Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Soon, your sweat can help you track your health
See More Glucose Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Glucose Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Glucose Health and other key companies, straight to your email.

About Glucose Health

Glucose Health (OTCMKTS:GLUC) engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.

View Glucose Health Profile

More Earnings Resources from MarketBeat